Amit Shah condoles death of Padma Shri oncologist Dr. Pankaj Shah
Synopsis
Key Takeaways
Union Home Minister Amit Shah on Thursday, July 2, 2026, expressed deep condolences on the passing of Padma Shri Dr. Pankaj M. Shah, vice-president of the Gujarat Cancer Society and a distinguished oncologist who dedicated his life to cancer treatment and research.
Context
Shah posted his tribute in Gujarati, calling the loss 'ક્યારેય ન પુરાય તેવી ખોટ' ('an irreplaceable void') for the world of medicine. He noted that Dr. Pankaj M. Shah had given 'a new life to countless cancer patients' and had devoted his entire life to medical service and cancer research. The minister closed with a prayer — ॐ શાંતિ શાંતિ શાંતિ (Om Shanti Shanti Shanti) — seeking peace for the departed soul and strength for the bereaved family.
Policy Backdrop
The Gujarat Cancer Society oversees the Gujarat Cancer Research Institute (GCRI), one of western India's oldest dedicated cancer centres, established in 1972 in Ahmedabad. The institute has served as an early model for public-private collaboration in oncology, aligned with the Government of India's National Cancer Control Programme launched in 1975 and subsequently strengthened under successive five-year plans to build regional cancer care capacity.
Dr. Pankaj M. Shah was a recipient of the Padma Shri, the national civilian honour conferred by the Government of India for distinguished service, in his case in the field of medicine and oncology. His decades of work at the Gujarat Cancer Society placed him among the senior architects of cancer care infrastructure in the state.
Stakeholders and Impact
Dr. Shah's passing is a significant loss for cancer patients, oncology researchers, and the broader medical community across Gujarat and western India. The Gujarat Cancer Research Institute has trained generations of oncologists and treated patients from across the region, and Dr. Shah's leadership shaped much of that institutional character.
Political leaders from Gujarat have a long tradition of publicly acknowledging physicians who built specialised health infrastructure in the state. Shah's tribute reflects the recognition that such medical figures occupy a prominent place in public life beyond their clinical roles.
What's Next
Attention will now turn to the leadership transition at the Gujarat Cancer Society and whether state or central health authorities announce any commemorative initiatives in Dr. Shah's honour. Any new oncology projects under the Gujarat government's health budget may also be dedicated to his memory, continuing the tradition of linking institutional milestones to the physicians who built them.